Mar Pujades‐Rodríguez

8.9k total citations · 2 hit papers
93 papers, 5.5k citations indexed

About

Mar Pujades‐Rodríguez is a scholar working on Infectious Diseases, Epidemiology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Mar Pujades‐Rodríguez has authored 93 papers receiving a total of 5.5k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Infectious Diseases, 22 papers in Epidemiology and 21 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Mar Pujades‐Rodríguez's work include HIV/AIDS Research and Interventions (30 papers), HIV Research and Treatment (15 papers) and HIV/AIDS drug development and treatment (13 papers). Mar Pujades‐Rodríguez is often cited by papers focused on HIV/AIDS Research and Interventions (30 papers), HIV Research and Treatment (15 papers) and HIV/AIDS drug development and treatment (13 papers). Mar Pujades‐Rodríguez collaborates with scholars based in United Kingdom, France and South Africa. Mar Pujades‐Rodríguez's co-authors include Harry Hemingway, Spiros Denaxas, Adam Timmis, Anoop D Shah, Eleni Rapsomaniki, Liam Smeeth, John Deanfield, Matthias Egger, Martin W. G. Brinkhof and Julie George and has published in prestigious journals such as The Lancet, JAMA and Circulation.

In The Last Decade

Mar Pujades‐Rodríguez

91 papers receiving 5.4k citations

Hit Papers

Blood pressure and incidence of twelve cardiovascular dis... 2014 2026 2018 2022 2014 2014 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1·25 million people
    2014 1.2k citations Eleni Rapsomaniki, Adam Timmis et al. The Lancet profile →
  2. Type 2 diabetes and incidence of cardiovascular diseases: a cohort study in 1·9 million people
    2014 817 citations Anoop D Shah, Eleni Rapsomaniki et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mar Pujades‐Rodríguez United Kingdom 37 1.8k 1.4k 1.2k 940 648 93 5.5k
Matthew S. Freiberg United States 45 1.3k 0.7× 1.7k 1.2× 1.9k 1.6× 801 0.9× 823 1.3× 176 6.7k
Jean Jacques Noubiap Cameroon 38 1.3k 0.8× 976 0.7× 1.4k 1.2× 694 0.7× 145 0.2× 244 5.3k
Lynda A. Szczech United States 51 1.9k 1.1× 2.3k 1.6× 1.1k 1.0× 399 0.4× 457 0.7× 141 10.7k
Saraladevi Naicker South Africa 36 805 0.5× 1.2k 0.9× 1.1k 0.9× 545 0.6× 251 0.4× 168 8.6k
Joseph A. Delaney United States 40 1.7k 1.0× 654 0.5× 859 0.7× 513 0.5× 249 0.4× 214 5.4k
Dorothea Nitsch United Kingdom 42 1.5k 0.8× 750 0.5× 1.0k 0.9× 611 0.7× 129 0.2× 241 7.5k
Joel Singer Canada 42 1.4k 0.8× 939 0.7× 2.7k 2.4× 263 0.3× 462 0.7× 188 7.9k
Deborah Wentworth United States 29 3.0k 1.7× 696 0.5× 1.3k 1.1× 2.8k 3.0× 594 0.9× 42 8.3k
Óscar Miró Spain 37 1.9k 1.1× 766 0.5× 1.1k 0.9× 133 0.1× 533 0.8× 491 6.2k
David A. Leaf United States 33 558 0.3× 1.3k 0.9× 949 0.8× 385 0.4× 572 0.9× 75 3.9k

Countries citing papers authored by Mar Pujades‐Rodríguez

Since Specialization
Citations

This map shows the geographic impact of Mar Pujades‐Rodríguez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mar Pujades‐Rodríguez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mar Pujades‐Rodríguez more than expected).

Fields of papers citing papers by Mar Pujades‐Rodríguez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mar Pujades‐Rodríguez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mar Pujades‐Rodríguez. The network helps show where Mar Pujades‐Rodríguez may publish in the future.

Co-authorship network of co-authors of Mar Pujades‐Rodríguez

This figure shows the co-authorship network connecting the top 25 collaborators of Mar Pujades‐Rodríguez. A scholar is included among the top collaborators of Mar Pujades‐Rodríguez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mar Pujades‐Rodríguez. Mar Pujades‐Rodríguez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Reyes‐Leiva, David, Álvaro Carbayo, Ricard Rojas‐García, et al.. (2024). Persistent symptoms, exacerbations and drug side effects despite treatment in myasthenia gravis. European Journal of Neurology. 32(1). e16463–e16463. 3 indexed citations
2.
Pujades‐Rodríguez, Mar, et al.. (2024). Temporal trends in age and stage-specific incidence of colorectal cancer in Saudi Arabia: A registry-based cohort study between 1997 and 2017. Cancer Epidemiology. 93. 102699–102699. 1 indexed citations
3.
Drozd, Michael, Mar Pujades‐Rodríguez, Ann W Morgan, et al.. (2022). Systemic Inflammation Is Associated With Future Risk of Fatal Infection: An Observational Cohort Study. The Journal of Infectious Diseases. 226(3). 554–562. 8 indexed citations
4.
Brellier, Florence, Mar Pujades‐Rodríguez, Kathleen Mudie, et al.. (2022). Incidence of Lyme disease in the United Kingdom and association with fatigue: A population-based, historical cohort study. PLoS ONE. 17(3). e0265765–e0265765. 3 indexed citations
5.
Iles, Mark M., et al.. (2022). Interplay between demographic, clinical and polygenic risk factors for severe COVID-19. International Journal of Epidemiology. 51(5). 1384–1395. 6 indexed citations
6.
Limumpornpetch, Padiporn, Ann W Morgan, Ana Tiganescu, et al.. (2022). The Effect of Endogenous Cushing Syndrome on All-cause and Cause-specific Mortality. The Journal of Clinical Endocrinology & Metabolism. 107(8). 2377–2388. 42 indexed citations
7.
Godec, Thomas, Daniel I. Bromage, Mar Pujades‐Rodríguez, et al.. (2022). Cardiovascular Outcomes Associated with Treatment of Type 2 Diabetes in Patients with Ischaemic Heart Failure. ESC Heart Failure. 9(3). 1608–1615. 3 indexed citations
8.
Yates, Max, Claire Owen, Sara Müller, et al.. (2020). Feasibility and Face Validity of Outcome Measures for Use in Future Studies of Polymyalgia Rheumatica: An OMERACT Study. The Journal of Rheumatology. 47(9). 1379–1384. 7 indexed citations
9.
Pujades‐Rodríguez, Mar, Ann W Morgan, Richard M. Cubbon, & Jianhua Wu. (2020). Dose-dependent oral glucocorticoid cardiovascular risks in people with immune-mediated inflammatory diseases: A population-based cohort study. PLoS Medicine. 17(12). e1003432–e1003432. 156 indexed citations
10.
Wu, Jianhua, Sarah Mackie, & Mar Pujades‐Rodríguez. (2020). Glucocorticoid dose-dependent risk of type 2 diabetes in six immune-mediated inflammatory diseases: a population-based cohort analysis. BMJ Open Diabetes Research & Care. 8(1). e001220–e001220. 42 indexed citations
11.
Alabas, Oras, Tomas Jernberg, Mar Pujades‐Rodríguez, et al.. (2019). Statistics on mortality following acute myocardial infarction in 842 897 Europeans. Cardiovascular Research. 116(1). 149–157. 29 indexed citations
12.
Schmidt, Amand F., Stefan Koudstaal, Mar Pujades‐Rodríguez, et al.. (2016). Heart failure following myocardial infarction: a cohort study of incidence and prognostic factors in 24 745 patients using linked electronic records. UCL Discovery (University College London). 1 indexed citations
13.
Timmis, Adam, Eleni Rapsomaniki, Sheng‐Chia Chung, et al.. (2016). Prolonged dual antiplatelet therapy in stable coronary disease: comparative observational study of benefits and harms in unselected versus trial populations. BMJ. 353. i3163–i3163. 12 indexed citations
14.
Rapsomaniki, Eleni, Adam Timmis, Julie George, et al.. (2014). Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1·25 million people. The Lancet. 383(9932). 1899–1911. 1152 indexed citations breakdown →
15.
Bergh, Rafaël Van den, K. Tayler‐Smith, Pamela Godia, et al.. (2013). Characteristics, medical management and outcomes of survivors of sexual gender-based violence, Nairobi, Kenya. Public Health Action. 3(2). 109–112. 14 indexed citations
16.
Bastard, Mathieu, Loretxu Pinoges, Suna Balkan, et al.. (2012). Timeliness of Clinic Attendance Is a Good Predictor of Virological Response and Resistance to Antiretroviral Drugs in HIV-Infected Patients. PLoS ONE. 7(11). e49091–e49091. 36 indexed citations
17.
Pujades‐Rodríguez, Mar, Emmanuelle Dantony, Loretxu Pinoges, et al.. (2011). Toxicity Associated with Stavudine Dose Reduction from 40 to 30 mg in First-Line Antiretroviral Therapy. PLoS ONE. 6(11). e28112–e28112. 18 indexed citations
18.
Nicholas, Sarala, Kalpana Sabapathy, Cecilia Ferreyra, Francis Varaine, & Mar Pujades‐Rodríguez. (2011). Incidence of Tuberculosis in HIV-Infected Patients Before and After Starting Combined Antiretroviral Therapy in 8 Sub-Saharan African HIV Programs. JAIDS Journal of Acquired Immune Deficiency Syndromes. 57(4). 311–318. 35 indexed citations
19.
Pujades‐Rodríguez, Mar. (2010). Treatment Failure and Mortality Factors in Patients Receiving Second-Line HIV Therapy in Resource-Limited Countries. JAMA. 304(3). 303–303. 89 indexed citations
20.
Todd, Jim, Heiner Grosskurth, John Changalucha, et al.. (2006). Risk Factors Influencing HIV Infection Incidence in a Rural African Population: A Nested Case‐Control Study. The Journal of Infectious Diseases. 193(3). 458–466. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Matthew S. Freiberg Breakdown of academic impact, for papers by Jean Jacques Noubiap Breakdown of academic impact, for papers by Lynda A. Szczech Breakdown of academic impact, for papers by Saraladevi Naicker Breakdown of academic impact, for papers by Joseph A. Delaney Breakdown of academic impact, for papers by Dorothea Nitsch Breakdown of academic impact, for papers by Joel Singer Breakdown of academic impact, for papers by Deborah Wentworth Breakdown of academic impact, for papers by Óscar Miró Breakdown of academic impact, for papers by David A. Leaf
Rankless by CCL
2026